| Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries M Mendelson, JA Røttingen, U Gopinathan, DH Hamer, H Wertheim, ... The Lancet 387 (10014), 188-198, 2016 | 207 | 2016 |
| Delinking investment in antibiotic research and development from sales revenues: the challenges of transforming a promising idea into reality K Outterson, U Gopinathan, C Clift, AD So, CM Morel, JA Røttingen PLoS medicine 13 (6), e1002043, 2016 | 56 | 2016 |
| Implementing large‐scale programmes to optimise the health workforce in low‐and middle‐income settings: a multicountry case study synthesis U Gopinathan, S Lewin, C Glenton Tropical Medicine & International Health 19 (12), 1437-1456, 2014 | 45 | 2014 |
| LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression R Øvstebø, HCD Aass, KBF Haug, AMS Trøseid, U Gopinathan, P Kierulf, ... Innate immunity 18 (4), 580-591, 2012 | 29 | 2012 |
| Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making Y Teerawattananon, C Painter, S Dabak, T Ottersen, U Gopinathan, ... Cost Effectiveness and Resource Allocation 19, 1-8, 2021 | 26 | 2021 |
| Conceptual and institutional gaps: understanding how the WHO can become a more effective cross-sectoral collaborator U Gopinathan, N Watts, D Hougendobler, A Lefebvre, A Cheung, ... Globalization and health 11, 1-13, 2015 | 24 | 2015 |
| Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a … F Tauqeer, K Myhr, U Gopinathan Health policy and planning 34 (6), 440-449, 2019 | 21 | 2019 |
| IL-10 immunodepletion from meningococcal sepsis plasma induces extensive changes in gene expression and cytokine release in stimulated human monocytes U Gopinathan, BS Brusletto, OK Olstad, P Kierulf, JP Berg, P Brandtzaeg, ... Innate Immunity 21 (4), 429-449, 2015 | 21 | 2015 |
| Promoting intersectoral collaboration through the evaluations of public health interventions: insights from key informants in 6 European countries S Kriegner, T Ottersen, JA Røttingen, U Gopinathan International Journal of Health Policy and Management 10 (2), 67, 2021 | 16 | 2021 |
| Extensive changes in transcriptomic “fingerprints” and immunological cells in the large organs of patients dying of acute septic shock and multiple organ failure caused by … BS Brusletto, EM Løberg, BC Hellerud, IL Goverud, JP Berg, OK Olstad, ... Frontiers in Cellular and Infection Microbiology 10, 42, 2020 | 16 | 2020 |
| Global effect of interleukin-10 on the transcriptional profile induced by Neisseria meningitidis in human monocytes U Gopinathan, R Øvstebø, OK Olstad, B Brusletto, HC Dalsbotten Aass, ... Infection and immunity 80 (11), 4046-4054, 2012 | 16 | 2012 |
| Towards a new global business model for antibiotics: Delinking revenues from sales C Clift, K Outterson, JA Røttingen Chatham House, 2015 | 14 | 2015 |
| The political origins of health inequity: the perspective of the Youth Commission on Global Governance for Health U Gopinathan, C Cuadrado, N Watts, RR Guinto, D Hougendobler, ... The Lancet 383 (9917), e12-e13, 2014 | 14 | 2014 |
| National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis EF Peacocke, SL Myhre, HS Foss, U Gopinathan PLoS Medicine 19 (3), e1003944, 2022 | 13 | 2022 |
| Global governance and the broader determinants of health: A comparative case study of UNDP’s and WTO’s engagement with global health U Gopinathan, N Watts, A Lefebvre, A Cheung, SJ Hoffman, JA Røttingen Global public health 14 (2), 175-189, 2019 | 13 | 2019 |
| Institutionalising an evidence-informed approach to guideline development: progress and challenges at the World Health Organization U Gopinathan, SJ Hoffman BMJ Global Health 3 (5), e000716, 2018 | 13 | 2018 |
| Evidence-Informed deliberative processes for Universal Health Coverage: broadening the scope: comment on" priority setting for Universal Health Coverage: We need evidence … U Gopinathan, T Ottersen International journal of health policy and management 6 (8), 473, 2017 | 12 | 2017 |
| Willingness to pay for a National Health Insurance Scheme in The Gambia: a contingent valuation study H Njie, KR Wangen, L Chola, U Gopinathan, I Mdala, JS Sundby, ... Health Policy and Planning 38 (1), 61-73, 2023 | 11 | 2023 |
| Antimicrobial resistance in a one health and one world perspective mechanisms and solutions AL Wester, U Gopinathan, K Gjefle, SØ Solberg, JR Røttingen International encyclopedia of public health, 2017 | 11 | 2017 |
| Dalsbotten Aass HC, Kierulf P, Brandtzaeg P, Berg JP. Global effect of interleukin-10 on the transcriptional profile induced by Neisseria meningitidis in human monocytes U Gopinathan, R Ovstebo, OK Olstad, B Brusletto Infect Immun 80 (11), 4046-54, 2012 | 11 | 2012 |
